We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.55%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$1.06T
AUM Growth
-$16.9B
Cap. Flow
-$16.2B
Cap. Flow %
-1.53%
Top 10 Hldgs %
26.1%
Holding
3,048
New
131
Increased
1,029
Reduced
1,524
Closed
112

Top Buys

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$2.39B
2
CVNA icon
Carvana
CVNA
+$1.82B
3
MSFT icon
Microsoft
MSFT
+$1.5B
4
DIS icon
Walt Disney
DIS
+$1.25B
5
SPOT icon
Spotify
SPOT
+$1.05B

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$2.65B
2
INTU icon
Intuit
INTU
+$2.08B
3
MTCH icon
Match Group
MTCH
+$1.87B
4
CRM icon
Salesforce
CRM
+$1.76B
5
META icon
Meta Platforms (Facebook)
META
+$1.61B

Sector Composition

Rank Sector Weight
1 Technology 25.08%
2 Healthcare 16.24%
3 Consumer Discretionary 15.33%
4 Communication Services 13.82%
5 Financials 12.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAGX icon
2951
Jaguar Health
JAGX
$3.73M
0
-$115K
JPM icon
2952
CALL
JPMorgan Chase
JPM
$967B
-10,000
Closed -$1.55M
KELYA icon
2953
Kelly Services Class A
KELYA
$547M
-598,863
Closed -$14.4M
KNSA icon
2954
Kiniksa Pharmaceuticals
KNSA
$6.13B
-13,231
Closed -$184K
KRMD icon
2955
KORU Medical Systems
KRMD
$157M
-14,100
Closed -$65K
LDI icon
2956
loanDepot
LDI
$305M
-503,653
Closed -$6.47M
LE icon
2957
Lands' End
LE
$396M
-5,162
Closed -$212K
LFST icon
2958
Lifestance Health
LFST
$4.66B
-14,094
Closed -$393K
LQDT icon
2959
Liquidity Services
LQDT
$1.34B
-8,964
Closed -$228K
MQ icon
2960
Marqeta
MQ
$1.67B
-625,000
Closed -$70.2M
MYFW icon
2961
First Western Financial
MYFW
$308M
-145,000
Closed -$3.75M
NCMI icon
2962
National CineMedia
NCMI
$240M
-606,860
Closed -$30.8M
OLMA icon
2963
Olema Pharmaceuticals
OLMA
$916M
-8,623
Closed -$241K
OXY.WS icon
2964
Occidental Petroleum Corp Warrants
OXY.WS
$33.3B
-38,727
Closed -$539K
PLRX icon
2965
Pliant Therapeutics
PLRX
$68.1M
-210,678
Closed -$6.13M
REKR icon
2966
Rekor Systems
REKR
$98.9M
-10,820
Closed -$110K
RFL icon
2967
Rafael Holdings
RFL
$112M
-6,697
Closed -$337K
ROOT icon
2968
Root
ROOT
$758M
-17,560
Closed -$3.42M
SAND
2969
DELISTED
Sandstorm Gold
SAND
-3,523,384
Closed -$27.8M
STEL
2970
DELISTED
Stellar Bancorp
STEL
-158,397
Closed -$4.33M
SWBI icon
2971
Smith & Wesson
SWBI
$639M
-8,097
Closed -$281K
TQQQ icon
2972
ProShares UltraPro QQQ
TQQQ
$38.9B
-24,800
Closed -$760K
VERV
2973
DELISTED
Verve Therapeutics
VERV
-685,000
Closed -$41.3M
WLFC icon
2974
Willis Lease Finance
WLFC
$1.16B
-15,885
Closed -$227K
WSBF icon
2975
Waterstone Financial
WSBF
$379M
-21,283
Closed -$418K

Similar funds

T. Rowe Price Associates's Q3 2021 Portfolio in Review

As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
  • T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
  • T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
  • T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
  • T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
  • T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.

Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.